Q2 2021 Holdings
Filed 2021-08-16 | 117 holdings | $39.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arrowhead Pharmaceuticals Inc(ARWR) | COM | 04280A100 | $17.3M | 208,600 | 43.3% |
| Arcturus Therapeutics Hldgs(ARCT) | COM | 03969T109 | $15.4M | 455,300 | 38.6% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $2.1M | 162,500 | 5.3% |
| Annovis BIO Inc COM(ANVS) | COM | 03615A108 | $1.0M | 12,000 | 2.6% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $911.0K | 13,500 | 2.3% |
| Coinbase Global Inc(COIN) | COM CL A | 19260Q107 | $684.0K | 2,700 | 1.7% |
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $682.0K | 102,500 | 1.7% |
| Champions Oncology Inc(CSBR) | COM NEW | 15870P307 | $514.0K | 50,000 | 1.3% |
| Affirm Hldgs Inc(AFRM) | COM CL A | 00827B106 | $337.0K | 5,000 | 0.8% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $328.0K | 12,000 | 0.8% |
| Cytosorbents Corp(CTSO) | COM NEW | 23283X206 | $265.0K | 35,000 | 0.7% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $90.0K | 6,500 | 0.2% |
| Cleveland-Cliffs Inc New(CLF) | COM | 185899101 | $65.0K | 3,000 | 0.2% |
| Staar Surgical Co(STAA) | COM PAR $0.01 | 852312305 | $35.3K | 231,600 | 0.1% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $17.0K | 1,500 | 0.0% |
| Clearside Biomedical Inc(CLSDUSD) | COM | 185063104 | $12.0K | 2,462,500 | 0.0% |
| Fubotv Inc(FUBO) | COM | 35953D104 | $8.6K | 268,000 | 0.0% |
| Aspira Womens Health Inc | COM | 04537Y109 | $6.4K | 1,130,720 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $4.5K | 465,000 | 0.0% |
| Cassava Sciences Inc(SAVA) | COM | 14817C107 | $3.8K | 45,000 | 0.0% |
| Icad Inc(ICADUSD) | COM NEW | 44934S206 | $3.8K | 222,000 | 0.0% |
| Unity Software Inc(U) | COM | 91332U101 | $3.3K | 30,100 | 0.0% |
| Upstart Hldgs Inc(UPST) | COM | 91680M107 | $3.1K | 24,800 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $2.9K | 25,900 | 0.0% |
| The Beauty Health Company(SKIN) | COM CL A | 88331L108 | $2.9K | 172,750 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $2.8K | 161,500 | 0.0% |
| F5 Networks Inc(FFIV) | COM | 315616102 | $2.7K | 14,500 | 0.0% |
| Inhibikase Therapeutics Inc COM | COM | 45719W106 | $2.5K | 875,000 | 0.0% |
| Affimed N V | COM | N01045108 | $2.4K | 287,600 | 0.0% |
| Neoleukin Therapeutics Inc | COM | 64049K104 | $2.2K | 239,000 | 0.0% |
| Novavax Inc(NVAX) | COM NEW | 670002401 | $2.2K | 10,300 | 0.0% |
| Inmode LTD COM(INMD) | COM | M5425M103 | $2.1K | 22,600 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $2.1K | 55,000 | 0.0% |
| Nuance Communications Inc | COM | 67020Y100 | $2.0K | 37,500 | 0.0% |
| Myovant Sciences LTD | COM | G637AM102 | $2.0K | 87,500 | 0.0% |
| Oncocyte Corporation | COM | 68235C107 | $1.9K | 330,000 | 0.0% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $1.9K | 10,500 | 0.0% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $1.8K | 116,900 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $1.8K | 12,600 | 0.0% |
| Oncternal Therapeutics Inc | COM | 68236P107 | $1.7K | 360,000 | 0.0% |
| Gores Holdings VI Inc | COM CL A | 38286R105 | $1.6K | 99,000 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $1.5K | 69,200 | 0.0% |
| Eiger Biopharmaceuticals Inc(CLDNEUR) | COM | 28249U105 | $1.4K | 158,500 | 0.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $1.3K | 19,075 | 0.0% |
| Surface Oncology Inc | COM | 86877M209 | $1.3K | 170,500 | 0.0% |
| Bioxcel Therapeutics Inc(BTAIEUR) | COM | 09075P105 | $1.2K | 42,000 | 0.0% |
| Marker Therapeutics Inc | COM | 57055L107 | $1.2K | 420,000 | 0.0% |
| Moderna Inc(MRNA) | COM | 60770K107 | $1.1K | 4,500 | 0.0% |
| Medicenna Therapeutics Corp(MDNAF) | COM | 58490H107 | $1.1K | 350,000 | 0.0% |
| Kala Pharmaceuticals Inc | COM | 483119103 | $1.0K | 190,000 | 0.0% |